Treatment efficacy of ledipasvir/sofosbuvir for 8 weeks in non-cirrhotic chronic hepatitis C genotype 4 patients | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Treatment efficacy of ledipasvir/sofosbuvir for 8 weeks in non-cirrhotic chronic hepatitis C genotype 4 patients

Babatin MA, AlGhamdi AS, Assiri AM, et al. Treatment efficacy of ledipasvir/sofosbuvir for 8 weeks in non-cirrhotic chronic hepatitis C genotype 4 patients. Saudi J Gastroenterol. 2019;25(1):55-60.

Publication Type:

Journal Article

Authors:

Babatin, MA; AlGhamdi, AS; Assiri, AM; et, al

Source:

Saudi J Gastroenterol, Volume 25, Issue 1, p.55-60 (2019)

Cited On:

Treatment-Naive Genotype 4 Without Cirrhosis

Export Citation:

RIS Format

Top